ArticlePharmaceutics2021

ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models.

Linxi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.